Walgreens' AI Strategy: How the Pharmacy Giant Is Rethinking Patient Experience in 2026

TL;DR#

Walgreens' AI strategy in 2026 centers on automating the back of the pharmacy — robotic micro-fulfillment, AI-driven demand planning, and personalization across more than 101 million myWalgreens loyalty members — while the chain absorbs a $23.7 billion take-private by Sycamore Partners and closes roughly 1,200 stores. Its 11 automated micro-fulfillment centers now fill prescriptions for thousands of its roughly 8,600 U.S. stores and have cut more than $500 million in costs. But the part of the patient relationship that drives switching, prescription abandonment, and lost trust still runs on static satisfaction surveys, IVR phone trees, and app-store ratings — instruments that capture a score, not the reason behind it. Medication non-adherence already costs the U.S. health system close to $300 billion a year, and prescription abandonment climbs past 45% when out-of-pocket cost crosses $125. Walgreens' robots can fill a script faster; they cannot explain why a patient never came to pick it up. Closing that "why" gap requires conversational AI interviews that let patients explain their reasoning in their own words — exactly the gap Perspective AI is built to close.

What is Walgreens' AI strategy?#

Walgreens' AI strategy is the company's coordinated use of robotics, machine learning, and automation to lower pharmacy operating costs, free pharmacists for clinical work, and personalize marketing across its retail and digital footprint. It pairs centralized robotic prescription fulfillment with AI-driven demand planning and loyalty personalization, deployed under acute financial pressure as the chain transitions from a public company to a private one owned by Sycamore Partners.

The strategy is best understood as an efficiency play first and a patient-experience play second. Walgreens told CNBC it expects its 11 micro-fulfillment centers to serve more than 5,000 stores, up from 4,800 in February 2025 and 4,300 in October 2023, with automation already handling roughly 60% of prescription volume for the stores it covers (CNBC, May 2025). That automation is the visible core of the turnaround. The less-visible question — whether patients feel better served — is where the strategy still leans on legacy listening tools.

The Walgreens Context: Scale and Financial Pressure in 2026#

Walgreens enters 2026 as one of the largest pharmacy operators in the United States, with roughly 8,600 U.S. stores and more than 101 million myWalgreens loyalty members generating billions of behavioral signals daily. In Q2 fiscal 2025 the company reported a 7.5% rise in quarterly revenue to $39.5 billion, even as it executed one of the most consequential structural changes in its history.

That change was financial. On March 6, 2025, Walgreens Boots Alliance agreed to be acquired by Sycamore Partners for $11.45 per share in cash, plus up to $3.00 per share in additional value tied to future monetization of its VillageMD businesses — a transaction valued at up to $23.7 billion (SEC Form 8-K, FY2025). Shareholders approved the deal with roughly 96% of votes cast in favor, and Walgreens began operating as a private standalone company on August 28, 2025, with Mike Motz appointed CEO.

The financial backdrop matters because it explains the shape of the AI strategy. A company closing approximately 1,200 stores over three years — including about 500 in 2025 — is not investing in technology for novelty. It is investing to protect margin and preserve patient access while the footprint shrinks. That is the same pressure now reshaping every regulated, high-volume customer relationship, from telehealth networks to large insurers, and it is why a named-company case study of how a pharmacy giant rethinks patient experience reads less like a tech story and more like a survival story.

Where Walgreens Uses AI Today#

Walgreens uses AI today in three concentrated areas: robotic prescription fulfillment, AI-driven demand planning and inventory, and loyalty personalization through its retail media and marketing stack. Each one targets cost or revenue — and each one is real, deployed, and measurable.

Robotic micro-fulfillment. The flagship initiative is a network of 11 automated micro-fulfillment centers that centralize the filling of routine, high-volume prescriptions away from individual stores. CNBC reported the program has cut more than $500 million in costs, with prescription fulfillment costs dropping nearly 13% year over year while volume handled by the centers surged (CNBC, May 2025). The stated goal is to free pharmacists from counting pills so they can deliver clinical services like vaccinations and testing — the higher-margin, higher-trust work that machines cannot do.

AI-driven demand planning. Walgreens has shifted from traditional print marketing to AI-driven demand planning and personalized outreach, using signals from its 101-million-member loyalty base to forecast inventory and tailor offers. This is the data layer beneath same-day delivery, app-based reordering, and the retail media network the company has built to monetize first-party data.

Loyalty and personalization. The myWalgreens app and loyalty program feed a personalization engine designed to deliver tailored content, suggestions, and rewards. Walgreens has described building "discovery tools" and customized recommendations on top of its delivery experience — classic AI personalization aimed at share-of-wallet.

What unites all three: they optimize the transaction. They make fulfillment cheaper, inventory smarter, and offers more relevant. None of them is designed to understand the patient's reasoning when something goes wrong — and in pharmacy, what goes wrong is rarely a fulfillment problem.

Why Pharmacy Automation Doesn't Solve the Patient-Understanding Problem#

Pharmacy automation does not solve the patient-understanding problem because the moments that drive switching and abandonment happen in the patient's head, not in the fulfillment queue. A robot can fill a prescription in seconds; it cannot tell you why the patient never came to pick it up, switched to a competitor, or stopped trusting the pharmacy as a health touchpoint.

Consider the scale of the gap. Medication non-adherence is estimated to cause roughly 125,000 deaths a year and cost the U.S. health system just under $300 billion annually (Patient Safety & Quality Healthcare analysis). Prescription abandonment is steeply cost-sensitive: rates stay below 5% when a prescription has no out-of-pocket cost but jump to 45% above $125 and to 60% above $500. In 2023, an estimated 98 million new-therapy prescriptions were abandoned in the U.S. These are not logistics failures. They are reasoning failures — cost shock, confusion about the medication, a bad counter interaction, distrust of the channel — and they are invisible to a fulfillment system optimized for throughput.

Walgreens' AI tells the company what happened: scripts filled, abandonment counts, NPS trends, app ratings. It does not capture why. CEO commentary itself frames the turnaround around engagement — "How we engage with customers is what is driving our success right now," Tim Wentworth said at a May 2025 town hall (InfotechLead) — yet the listening instruments behind that engagement are still the same static tools every large operator defaults to. The same structural blind spot is why we argue that AI-first customer research cannot start with a web form: a form can record a 1-to-5 satisfaction score, but it cannot ask the patient who rated their pharmacy a 2, "What happened the last time you tried to pick up your prescription?"

How Forms and IVR Bottleneck Patient Listening#

Forms, satisfaction surveys, and IVR phone trees bottleneck patient listening because they force a messy, emotional, often clinical experience into pre-written fields — and they cannot follow up. A patient who abandons a prescription has a story; a survey gives them a dropdown.

Here is how the three legacy instruments fail in a pharmacy context:

The deeper problem is that forms front-load effort before value. A patient juggling a new diagnosis, a copay surprise, and a confusing label is not going to fill out a 12-question survey — so the people whose experience matters most are exactly the ones who never respond. NPS and CSAT survey response rates routinely sit in the single-to-low-double digits, which means the data Walgreens acts on over-represents the calm, satisfied minority. This is the same dynamic we documented in why conversations beat surveys for real customer research: the highest-value insight lives in the answers a static form is structurally incapable of collecting.

IVR makes it worse in healthcare specifically. A phone tree built to route calls efficiently treats a patient's confusion as a routing problem, not a research opportunity. The patient who presses "2 for refills" three times and hangs up is a churn signal — but the system logs an abandoned call, not the reason.

What Conversational AI Interviews Unlock for a Pharmacy#

Conversational AI interviews unlock the reasoning behind patient behavior at the same scale Walgreens already operates — letting the chain ask thousands of patients why they switched, abandoned, or distrusted a touchpoint, in their own words, with intelligent follow-up. Instead of a score, the pharmacy gets the story behind the score.

This is what Perspective AI's interviewer agent does: it runs hundreds or thousands of AI-led interviews simultaneously, follows up on vague or emotional answers, and probes for the "why now" that a form can never reach. For a pharmacy operator the use cases map directly onto the abandonment and trust problems above:

• Prescription abandonment. When a script goes unfilled, an AI interview can ask the patient what stopped them — cost, confusion, a side-effect fear, a competitor's offer — and probe the specific barrier. That is the difference between knowing 45% abandon and knowing which 45% abandon for cost versus confusion, which determine completely different interventions.
• Pharmacy switching. A patient who moved their prescriptions to a competitor can explain the actual trigger — wait times, a counter interaction, an app failure, an insurance hassle — rather than checking "service" on a churn survey. This is the same playbook we describe in the complete guide to voice-of-customer programs in 2026.
• Clinical-service adoption. As pharmacists shift to vaccinations, testing, and counseling, conversational research can reveal why patients do or don't trust the pharmacy for clinical care — a sensitive question that demands nuance no checkbox can hold.
• Continuous, always-on listening. Rather than a quarterly survey, a concierge agent can replace a static intake form at the moment of friction, capturing context while it's fresh. This continuous-learning cadence is the core of any modern voice-of-customer program built from scratch.

Crucially, conversational AI can scale to match Walgreens' footprint. The same automation logic that lets 11 fulfillment centers serve 5,000 stores lets one AI interviewer run thousands of patient conversations at once — moving beyond NPS to the why behind the score without hiring an army of researchers. Other regulated giants are already building this muscle, as documented in case studies of how a major health insurer is modernizing member experience and how a telehealth network handles 80 million visits.

Handling sensitive health context responsibly#

Conversational AI in pharmacy must be designed for a clinical, regulated, emotionally charged context — which means consent, privacy, and the ability to escalate to a human are non-negotiable. AI interviews are well suited to research and feedback ("Why did you abandon this prescription?") but should never substitute for clinical advice or a pharmacist's judgment. The goal is to understand the patient's experience and reasoning so the human-delivered care improves — not to automate the care itself. Any health claims a pharmacy acts on must still be validated by licensed professionals; the AI's job is to surface the why at scale so those professionals can act on it.

How Walgreens' AI Strategy Compares to Its Peers#

Walgreens' AI strategy compares to its healthcare peers as automation-heavy on operations but conventional on patient listening — a pattern that holds across most large, regulated incumbents in 2026. The efficiency layer is sophisticated; the understanding layer lags.

The takeaway is consistent with what we see across verticals in the 2026 customer research stack: incumbents have largely solved AI for operations and advertising, and have barely started on AI for understanding. The same gap appears in fintech and insurance case studies, from how a top-five carrier modernizes customer experience to a member-first fintech's conversational discovery. Walgreens has the data and the scale; what it lacks is a listening instrument that matches the sophistication of its fulfillment robots.

Frequently Asked Questions#

What is Walgreens doing with AI in 2026?#

Walgreens is using AI primarily for robotic prescription fulfillment, AI-driven demand planning, and loyalty personalization. Its 11 automated micro-fulfillment centers handle roughly 60% of prescription volume for the stores they serve and have cut more than $500 million in costs. The chain also applies AI to inventory forecasting and to personalized marketing across more than 101 million myWalgreens loyalty members, all under financial pressure following its take-private by Sycamore Partners.

How is AI changing the Walgreens pharmacy experience?#

AI is changing the Walgreens pharmacy experience mainly by moving routine pill-counting to centralized robots, which is meant to free pharmacists for clinical services like vaccinations, testing, and counseling. The intent is faster fulfillment and more pharmacist time with patients. What automation does not change is the chain's ability to understand why patients abandon prescriptions or switch pharmacies — that still depends on the quality of its patient-listening tools.

Why doesn't pharmacy automation improve patient understanding?#

Pharmacy automation doesn't improve patient understanding because it optimizes the transaction, not the relationship. Robots and demand-planning AI tell Walgreens what happened — scripts filled, abandonment counts, NPS scores — but not why. With U.S. medication non-adherence costing nearly $300 billion a year and abandonment exceeding 45% above $125 in out-of-pocket cost, the high-value insight lives in patient reasoning that fulfillment systems never capture.

How can conversational AI help pharmacies like Walgreens?#

Conversational AI helps pharmacies by interviewing patients at scale about the reasons behind their behavior, with intelligent follow-up that surveys and IVR cannot match. It can ask why a patient abandoned a prescription, switched pharmacies, or distrusts a clinical service, and probe the specific barrier in the patient's own words. Because the interviews run in parallel, a pharmacy can reach thousands of patients without hiring researchers.

Is conversational AI safe to use in a regulated healthcare setting?#

Conversational AI is appropriate for research and feedback in healthcare when it is designed around consent, privacy, and human escalation. It should capture patient experience and reasoning — not deliver clinical advice or replace a pharmacist's judgment. Any health-related decisions a pharmacy makes from the insights must still be validated by licensed professionals; the AI's role is to surface the "why" at scale so human care improves.

Conclusion#

Walgreens' AI strategy is a genuine, measurable success on the dimension it was built for: automation has cut more than $500 million in costs, robots fill the majority of routine prescriptions, and AI-driven personalization reaches more than 101 million loyalty members. But efficiency is only half of a patient relationship. The moments that decide whether a patient stays, fills, adheres, and trusts — the $300-billion-a-year non-adherence problem, the 45%-plus abandonment cliff, the quiet switch to a competitor — still run on satisfaction surveys, IVR trees, and app ratings that capture a score and miss the reason.

That is the gap a Walgreens AI strategy built for 2026 has to close next. The chain has already proven it can scale automation to thousands of stores; the same scale logic applies to understanding. Conversational AI interviews let a pharmacy ask thousands of patients why — in their own words, with follow-up, in a sensitive health context handled responsibly. If your team is trying to move from counting patient scores to understanding patient reasoning, start a study with Perspective AI or see how it works for CX teams. For pharmacy and healthcare operators, the next competitive edge isn't a faster robot — it's finally hearing the patient explain themselves.